Get started
Author

Niranjan Awasthi

Posterior Capsular Opacification
2009 · Niranjan Awasthi · Archives of Ophthalmology · 385
Factors influencing the degradation of soil-applied endosulfan isomers
2000 · Niranjan Awasthi, Rajiv Ahuja, et al. · Soil Biology and Biochemistry · 133
Comparative benefits of Nab-paclitaxel over gemcitabine or polysorbate-based docetaxel in experimental pancreatic cancer
2013 · N. Awasthi, C. Zhang, et al. · Carcinogenesis · 126
PDF
A C-X-C Chemokine Receptor Type 2–Dominated Cross-talk between Tumor Cells and Macrophages Drives Gastric Cancer Metastasis
2019 · Zhijun Zhou, Guanggai Xia, et al. · Clinical Cancer Research · 123
PDF
A positive crosstalk between CXCR4 and CXCR2 promotes gastric cancer metastasis
2017 · Z Xiang, Z-J Zhou, et al. · Oncogene · 97
CXCL1 promotes tumor growth through VEGF pathway activation and is associated with inferior survival in gastric cancer
2015 · Zhe-Wei Wei, Guang-Kai Xia, et al. · Cancer Letters · 96
The efficacy of a novel, dual PI3K/mTOR inhibitor NVP‐BEZ235 to enhance chemotherapy and antiangiogenic response in pancreatic cancer
2011 · Niranjan Awasthi, Peter L. Yen, et al. · Journal of Cellular Biochemistry · 86
BMS-754807, a Small-Molecule Inhibitor of Insulin-like Growth Factor-1 Receptor/Insulin Receptor, Enhances Gemcitabine Response in Pancreatic Cancer
2012 · Niranjan Awasthi, Changhua Zhang, et al. · Molecular Cancer Therapeutics · 73
Downregulation of MMP-2 and -9 by Proteasome Inhibition: A Possible Mechanism to Decrease LEC Migration and Prevent Posterior Capsular Opacification
2008 · Niranjan Awasthi, Shuh Tuan Wang-Su, et al. · Investigative Ophthalmology & Visual Science · 71
Profile of nintedanib in the treatment of solid tumors: the evidence to date
2015 · Niranjan Awasthi, Roderich Schwarz · OncoTargets and Therapy · 68
PDF
PG545, an Angiogenesis and Heparanase Inhibitor, Reduces Primary Tumor Growth and Metastasis in Experimental Pancreatic Cancer
2013 · Katherine T. Ostapoff, Niranjan Awasthi, et al. · Molecular Cancer Therapeutics · 67
PDF
Endothelial monocyte activating polypeptide II interferes with VEGF-induced proangiogenic signaling
2008 · Niranjan Awasthi, Margaret A Schwarz, et al. · Laboratory Investigation · 65
PDF
Nintedanib, a triple angiokinase inhibitor, enhances cytotoxic therapy response in pancreatic cancer
2014 · Niranjan Awasthi, Stefan Hinz, et al. · Cancer Letters · 62
Suppression of Human Lens Epithelial Cell Proliferation by Proteasome Inhibition, a Potential Defense against Posterior Capsular Opacification
2006 · Niranjan Awasthi, B. J. Wagner · Investigative Ophthalmology & Visual Science · 60
Upregulation of Heat Shock Protein Expression by Proteasome Inhibition: An Antiapoptotic Mechanism in the Lens
2005 · Niranjan Awasthi, B. J. Wagner · Investigative Ophthalmology & Visual Science · 55
Specific Activation of the Glucocorticoid Receptor and Modulation of Signal Transduction Pathways in Human Lens Epithelial Cells
2007 · Vanita Gupta, Niranjan Awasthi, et al. · Investigative Ophthalmology & Visual Science · 54
Dual inhibition of the PI3K and MAPK pathways enhances nab-paclitaxel/gemcitabine chemotherapy response in preclinical models of pancreatic cancer
2019 · Niranjan Awasthi, David Kronenberger, et al. · Cancer Letters · 50
Inhibition of the MEK/ERK pathway augments nab-paclitaxel-based chemotherapy effects in preclinical models of pancreatic cancer
2017 · Niranjan Awasthi, Sheena Monahan, et al. · Oncotarget · 36
PDF
Evaluation of Poly-Mechanistic Antiangiogenic Combinations to Enhance Cytotoxic Therapy Response in Pancreatic Cancer
2012 · Niranjan Awasthi, Changhua Zhang, et al. · PLoS ONE · 35
PDF
Antitumor effects of EMAP II against pancreatic cancer through inhibition of fibronectin-dependent proliferation
2010 · Roderich E. Schwarz, Niranjan Awasthi, et al. · Cancer Biology & Therapy · 35
PDF
Superior Antitumor Activity of Nanoparticle Albumin-Bound Paclitaxel in Experimental Gastric Cancer
2013 · Changhua Zhang, Niranjan Awasthi, et al. · PLoS ONE · 33
PDF
Nab-Paclitaxel in the Treatment of Gastrointestinal Cancers—Improvements in Clinical Efficacy and Safety
2023 · Md Sazzad Hassan, Niranjan Awasthi, et al. · Biomedicines · 32
PDF
Therapeutic efficacy of anti‐MMP9 antibody in combination with nab‐paclitaxel‐based chemotherapy in pre‐clinical models of pancreatic cancer
2019 · Niranjan Awasthi, Amanda J. Mikels‐Vigdal, et al. · Journal of Cellular and Molecular Medicine · 32
PDF
The dual PI3K/mTOR inhibitor NVP-BEZ235 enhances nab-paclitaxel antitumor response in experimental gastric cancer
2013 · CHANG-HUA ZHANG, NIRANJAN AWASTHI, et al. · International Journal of Oncology · 32
PDF
Immunoproteasome expression in a nonimmune tissue, the ocular lens
2002 · Shaneen Singh, Niranjan Awasthi, et al. · Archives of Biochemistry and Biophysics · 32
Works count: 177
Citation count: 2,333
H-index: 27
I10-index: 48
Year
Topic
Type